General Discussion
In reply to the discussion: i'm just going to POST THIS AS LOUD AS I CAN and crush all arguments-MONSANTO=root of all evil. [View all]farminator3000
(2,117 posts)if you aren't up on medical MJ, the THC (and CBD) are the medicine, so trying to take it out is basically the dumbest thing i've ever heard...
Researchers from the College of Biological Science of the University of Minnesota have identified the genes in the Cannabis plant that produce tetra-hydro-cannabinol (THC), claiming in a press release that it is a first step toward engineering a drug-free Cannabis plant. George Weiblen, an associate professor of plant biology and a co-author of the study, said Cannabis genetics can contribute to better agriculture, medicine, and drug enforcement.
http://coto2.wordpress.com/2010/10/25/prop-19-monsanto-and-gmo-terminator-cannabis/
(very long ^^^, from 2 years ago...things are worse now, no doubt!)
At his Amsterdam glasshouses, he nods conspiratorially at the healthy- looking garden produce. Dont say anything yet, but we are also working on putting THC into tomatoes, he confides. Then he cackles reassuringly: Only kidding!
David Watson has stated HortaPharm has built up over many years the most extensive Living Library of Medicinal Cannabis varieties in the world.
-skip-
Under the agreement GW Pharma will be responsible for the development of specific drug delivery technologies to administer the pharmaceutical grade medicinal cannabis. This work will include a vaporizer for which HortaPharm has a patent pending.
(look up Sativex, they did it!)
-skip-
Physicians will be able to monitor patient usage remotely, continued Guy. People wont be able to tamper with our devices, even though they are portable and easy to use. Youd need a metal saw or a blowtorch to get into one of them. These controls answer concerns of those who worry that our extracts will be used inappropriately. And, these devices can be adapted for other medicines, ensuring patient safety and medical efficacy.
Dr Guy and his representatives have engaged in high level discussions with the DEA, FDA, the Office for National Drug Control Policy (ONDCP), National Institute for Drug Abuse (NIDA) and senior state officials in California and Maine.
-skip-
GW occupies a lead position world-wide, concludes Guy. We are uniquely placed to become the first company to achieve regulatory approval for prescription cannabis-based medicines.
-skip-
http://www.cannabisculture.com/node/19879
Patented Pot vs. the Herbal Gold Standard by David Malmo-Levine
How patented marijuana strains and medicines may threaten the re-legalization movement, curb information sharing, set up a monopoly for certain breeders and medicine producers and limit users to a more expensive and inferior product. Their economic value to the pharmaceutical houses which produce them will be directly proportional to the severity of the prohibition against the use of cannabis.
-skip-
GW Pharmaceutical was granted a license to grow cannabis for medical research in 1998 and its partner Bayer was granted a patent for Sativex in 2006. Sativex comes in a 5.5 ml spray bottle for $102 U.S. Dollars, which supplies about 51 sprays enough for an average ten day supply. It is now available in Canada for MS and cancer pain, and has most recently become available in Britain and parts of Spain for use in the treatment of some other symptoms and syndromes.
GW Pharmaceutical has even patented a strain of cannabis called Grace in Canada. It was patented in 2005 under the Plant Breeders Rights Act. Under this 1994 Act, all plant species (except algae, bacteria, and fungi) are eligible for protection (exclusive rights to sell) for 18 years. Medicine patents last between ten to twenty years depending on the country.
-skip-
The modern version of this monopoly began in 1910 with the Flexner Report a report that succeeded in closing down all the naturopathic and herbal medicine schools by the 1930′s. This report was partially engineered by the Rockefeller Foundation. The removal of these schools would assist the Rockefeller family in protecting their investments in pharmaceuticals from botanical competition. The Rockefeller Institute and Rockefeller Foundation were also key players in the development of the sciences of genetics and molecular biology the fields in which the concepts of patenting of life-forms originated. Standard Oil now Exxon/Mobil and a host of other oil companies was the Rockefeller Foundations source of income. Interestingly, in 1927 Standard Oil became business partners with Bayer the marketer and distributor of Sativex in Canada.